Showing results (1261-1270 of 1,532) with videos related to

Sort By:
Pageof 154
Proceedings of the National Academy of Sciences of the United States of America|November 19, 2015
JAK inhibition alleviates the cellular senescence-associated secretory phenotype and frailty in old ageMing Xu, Tamara Tchkonia, Husheng Ding, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|August 13, 2016
Transplanted Senescent Cells Induce an Osteoarthritis-Like Condition in MiceMing Xu, Elizabeth W Bradley, Megan M Weivoda, et al.
Communications Biology|August 11, 2022
GAWMerge expands GWAS sample size and diversity by combining array-based genotyping and whole-genome sequencingRavi Mathur, Fang Fang, Nathan Gaddis, et al.
Annals of the American Thoracic Society|July 30, 2014
Beyond cigarettes per day. A genome-wide association study of the biomarker carbon monoxideA Joseph Bloom, Sarah M Hartz, Timothy B Baker, et al.
Angewandte Chemie (International Ed. in English)|February 9, 2023
Chemical Validation of Mycobacterium tuberculosis Phosphopantetheine Adenylyltransferase Using Fragment Linking and CRISPR InterferenceJamal El Bakali, Michal Blaszczyk, Joanna C Evans, et al.
Elife|December 22, 2015
Targeting senescent cells enhances adipogenesis and metabolic function in old ageMing Xu, Allyson K Palmer, Husheng Ding, et al.
Cancer Immunology Research|February 9, 2023
Combination IFNβ and Membrane-Stable CD40L Maximize Tumor Dendritic Cell Activation and Lymph Node Trafficking to Elicit Systemic T-cell ImmunityHong Zheng, Xiaoqing Yu, Mohammed L Ibrahim, et al.
Biological Psychiatry|July 26, 2017
Association Between Substance Use Disorder and Polygenic Liability to SchizophreniaSarah M Hartz, Amy C Horton, Mary Oehlert, et al.
AIDS Patient Care and Stds|August 8, 2020
Resilience and HIV Treatment Outcomes Among Women Living with HIV in the United States: A Mixed-Methods AnalysisFaith E Fletcher, Nicholas R Sherwood, Whitney S Rice, et al.
Diabetes, Obesity & Metabolism|June 4, 2010
A one-year study to assess the safety and efficacy of the CB1R inverse agonist taranabant in overweight and obese patients with type 2 diabetesM S Kipnes, P Hollander, K Fujioka, et al.
Pageof 154